Genus PLC
01 November 2005
Genus plc
01 November 2005
FOR IMMEDIATE RELEASE
NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION IN WHOLE OR IN PART IN OR INTO THE
EXCLUDED TERRITORIES
GENUS PLC
___________________________________________________________________________
RECOMMENDED OFFER FOR SYGEN INTERNATIONAL PLC
Posting of Offer and Admission Documents
Genus plc ('Genus') announces that yesterday it posted the Offer Document and
the Admission Document in connection with the recommended offer by Bridgewell
Securities Limited on behalf of Genus for Sygen International Plc ('Sygen') for
a total cash consideration of approximately £188 million (the 'Offer'). The
first closing date of the Offer is 21 November 2005.
An extraordinary general meeting ('EGM') of the shareholders of Genus has been
convened in connection with, among other things, the Offer by means of a notice
of EGM posted yesterday to the shareholders of Genus. The EGM will be held at
the offices of Berwin Leighton Paisner, St. Magnus House, 3 Lower Thames Street,
London EC3R 6HA at 11:00 am on 25 November 2005.
___________________________________________________________________________
Enquiries
Genus Telephone: 01256 347 107
Richard Wood / David Timmins
Bridgewell Securities Limited Telephone: 020 7003 3000
Greg Aldridge / Fred Ward
Panmure Gordon (Broking) Limited Telephone: 020 7459 3600
Edward Farmer / Mark Lander
Certain terms used in this announcement have the same meanings as in Genus' Rule
2.5 Offer Announcement released on the 28 October 2005.
This announcement is issued by Bridgewell Securities Limited, which is
authorised and regulated in the United Kingdom by the Financial Services
Authority. Bridgewell Securities Limited is acting exclusively for Genus and no
one else in connection with the Offer and will not be responsible to anyone
other than Genus for providing the protections afforded to customers of
Bridgewell Securities Limited nor for providing advice in relation to the Offer.
Panmure Gordon (Broking) Limited, which is authorised and regulated in the
United Kingdom by the Financial Services Authority for investment business
activities, is acting exclusively for Genus and no one else and will not be
responsible to anyone other than Genus for providing the protections afforded to
customers of Panmure Gordon nor for providing advice in relation to the Offer.
The release, publication or distribution of this announcement in jurisdictions
other than the United Kingdom may be restricted by law and therefore persons in
such jurisdictions into which this announcement is released, published or
distributed should inform themselves about, and observe, such restrictions. Any
failure to comply with the restrictions may constitute a violation of the
securities laws of any such jurisdiction.
The Offer is not being made, directly or indirectly, in or into, or by use of
the mails of, or by any means or instrumentality (including, without limitation,
facsimile transmission, internet, email, telex or telephone) of interstate or
foreign commerce of, or any facility of a national state or other securities
exchange of, the Excluded Territories and subject to certain exceptions cannot
be accepted by any such use, means instrumentality or facility or from the
Excluded Territories.
Neither the Offer nor the Placing constitutes an offer of securities for sale,
or the solicitation of an offer to buy, securities in the United States and the
Placing Shares to be issued pursuant to the Placing have not been and will not
be registered under the United States Securities Act of 1933, or under the laws
of any state, district or other jurisdiction of the Excluded Territories and no
regulatory clearances in respect of Placing Shares have been or will be, applied
for in any jurisdiction. Accordingly, unless an exemption under the US
Securities Act of 1933 or other relevant securities laws is applicable, the
Placing Shares are not being, and may not be offered, sold, resold, delivered or
distributed, directly or indirectly, in or into any of the Excluded Territories
or to, or for the account or benefit of, any person resident in any of the
Excluded Territories.
This information is provided by RNS
The company news service from the London Stock Exchange
AI Summary Disclaimer BETA
The content you are viewing has been generated or assisted by artificial
intelligence (AI). While efforts are made to ensure accuracy and clarity, AI-generated text may
contain inaccuracies, outdated information, or subjective interpretations. This content is intended
for general informational purposes only and should not be considered professional advice or factual
confirmation.
We encourage you to independently verify any information provided,
especially if it will be relied upon for making decisions or taking action. Any reliance you place
on this material is strictly at your own risk. The AI system that produced this content cannot
assess the specifics of individual circumstances, and results may vary based on context and
individual needs.
*A Private Investor is a recipient of the information who meets all of the conditions set out below, the recipient:
Obtains access to the information in a personal capacity;
Is not required to be regulated or supervised by a body concerned with the regulation or supervision of investment or financial services;
Is not currently registered or qualified as a professional securities trader or investment adviser with any national or state exchange, regulatory authority, professional association or recognised professional body;
Does not currently act in any capacity as an investment adviser, whether or not they have at some time been qualified to do so;
Uses the information solely in relation to the management of their personal funds and not as a trader to the public or for the investment of corporate funds;
Does not distribute, republish or otherwise provide any information or derived works to any third party in any manner or use or process information or derived works for any commercial purposes.
Please note, this site uses cookies. Some of the cookies are essential for parts of the site to operate and have already been set. You may delete and block all cookies from this site, but if you do, parts of the site may not work. To find out more about the cookies used on Investegate and how you can manage them, see our Privacy and Cookie Policy
To continue using Investegate, please confirm that you are a private investor as well as agreeing to our Privacy and Cookie Policy & Terms.
Create an Account
Create your FREE account to receive personalised announcements, watchlists, market updates, investment insights and new features.
Personalise your experience
Tell us a little about yourself to receive personalised content, announcements and relevant investment opportunities.